Day CL Jr - Search Results

1

Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection.

Rowe DE, Carroll RJ, Day CL Jr. Rowe DE, et al. Among authors: day cl jr. J Am Acad Dermatol. 1992 Jun;26(6):976-90. doi: 10.1016/0190-9622(92)70144-5. J Am Acad Dermatol. 1992. PMID: 1607418 Review.

2

Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma.

Rowe DE, Carroll RJ, Day CL Jr. Rowe DE, et al. Among authors: day cl jr. J Dermatol Surg Oncol. 1989 Apr;15(4):424-31. doi: 10.1111/j.1524-4725.1989.tb03249.x. J Dermatol Surg Oncol. 1989. PMID: 2925988

3

Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up.

Rowe DE, Carroll RJ, Day CL Jr. Rowe DE, et al. Among authors: day cl jr. J Dermatol Surg Oncol. 1989 Mar;15(3):315-28. doi: 10.1111/j.1524-4725.1989.tb03166.x. J Dermatol Surg Oncol. 1989. PMID: 2646336 Review.

4

Eruptive widespread Spitz nevi.

Smith SA, Day CL Jr, Vander Ploeg DE. Smith SA, et al. Among authors: day cl jr. J Am Acad Dermatol. 1986 Nov;15(5 Pt 2):1155-9. doi: 10.1016/s0190-9622(86)70286-7. J Am Acad Dermatol. 1986. PMID: 3771869

5

Prognosis of clinical stage I melanoma patients with positive elective regional node dissection.

Koh HK, Sober AJ, Day CL Jr, Lew RA, Kopf AW, Lamar W, Ben Cosimi A, Wood WC, Mihm MC Jr, Malt RA, et al. Koh HK, et al. Among authors: day cl jr. J Clin Oncol. 1986 Aug;4(8):1238-44. doi: 10.1200/JCO.1986.4.8.1238. J Clin Oncol. 1986. PMID: 3734848

6

Expression of activation antigens by T cells infiltrating basal cell carcinomas.

Guillén FJ, Day CL Jr, Murphy GF. Guillén FJ, et al. Among authors: day cl jr. J Invest Dermatol. 1985 Sep;85(3):203-6. doi: 10.1111/1523-1747.ep12276675. J Invest Dermatol. 1985. PMID: 3875662 Free article.

7

Malignant melanoma prognostic factors 7: elective lymph node dissection.

Day CL Jr, Lew RA. Day CL Jr, et al. J Dermatol Surg Oncol. 1985 Mar;11(3):233-9. doi: 10.1111/j.1524-4725.1985.tb03000.x. J Dermatol Surg Oncol. 1985. PMID: 3882797 Clinical Trial.

8

Malignant melanoma prognostic factors 6: distant metastases and length of survival.

Day CL Jr, Lew RA. Day CL Jr, et al. J Dermatol Surg Oncol. 1984 Sep;10(9):686-9. doi: 10.1111/j.1524-4725.1984.tb01274.x. J Dermatol Surg Oncol. 1984. PMID: 6480971

9

Cigarette smoking and malignant melanoma. Prognostic implications.

Koh HK, Sober AJ, Day CL Jr, Lew RA, Fitzpatrick TB. Koh HK, et al. Among authors: day cl jr. Cancer. 1984 Jun 1;53(11):2570-3. doi: 10.1002/1097-0142(19840601)53:11<2570::aid-cncr2820531135>3.0.co;2-k. Cancer. 1984. PMID: 6713354

10

"Microscopic satellites" are more highly associated with regional lymph node metastases than is primary melanoma thickness.

Harrist TJ, Rigel DS, Day CL Jr, Sober AJ, Lew RA, Rhodes AR, Harris MN, Kopf AW, Friedman RJ, Golomb FM, et al. Harrist TJ, et al. Among authors: day cl jr. Cancer. 1984 May 15;53(10):2183-7. doi: 10.1002/1097-0142(19840515)53:10<2183::aid-cncr2820531029>3.0.co;2-9. Cancer. 1984. PMID: 6704906

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page